{"id":514240,"date":"2021-07-16T19:03:11","date_gmt":"2021-07-16T23:03:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/"},"modified":"2021-07-16T19:03:11","modified_gmt":"2021-07-16T23:03:11","slug":"investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/","title":{"rendered":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021"},"content":{"rendered":"

<\/p>\n

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nThe law firm of Kirby McInerney LLP<\/a> announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Frequency Therapeutics, Inc. (\u201cFrequency\u201d or the \u201cCompany\u201d) (NASDAQ: FREQ<\/a>) securities from November 16, 2020 through March 22, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.\n<\/p>\n

\nFrequency is a Massachusetts-based pharmaceutical company focused on the development of treatments for hearing loss, including its drug \u201cFX-322.\u201d Frequency has conducted several clinical studies evaluating the safety and effectiveness of FX-322, the most significant of which was a Phase 2a study that began in October 2019.\n<\/p>\n

\nIn April 2020, Frequency\u2019s Chief Executive Officer (\u201cCEO\u201d), David L. Lucchino, began selling his shares of Frequency, totaling over 350,000 shares sold and earning over $10.5 million.\n<\/p>\n

\nOn March 23, 2021, before the market opened, Frequency disclosed in a press release disappointing interim results of the Phase 2a study, revealing that subjects who had mild to moderate sensorineural hearing loss did not demonstrate improvements in hearing measures versus placebo. On this news, Frequency\u2019s stock price declined by $28.30 per share, or approximately 78%, from $36.29 per share to close at $7.99 per share on March 23, 2021, thereby damaging investors.\n<\/p>\n

\nThe lawsuit alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that Frequency\u2019s Phase 2a study did not yield positive results to support the commercialization of FX-322; and (2) that, as a result, Defendants\u2019 statements about its business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.\n<\/p>\n

\nIf you purchased or otherwise acquired Frequency securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod<\/a> of Kirby McInerney LLP<\/a> at 212-371-6600, by email at investigations@kmllp.com<\/a>, or by filling out this contact form<\/a>, to discuss your rights or interests with respect to these matters without any cost to you.\n<\/p>\n

Kirby McInerney LLP<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website: http:\/\/www.kmllp.com<\/a>.\n<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210716005469\/en\/<\/a><\/span><\/p>\n

\nKirby McInerney LLP
\n
Thomas W. Elrod, Esq.
\n
212-371-6600
\n
https:\/\/www.kmllp.com
\n<\/a>
investigations@kmllp.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America New York<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 NEW YORK–(BUSINESS WIRE)– The law firm of Kirby McInerney LLP announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Frequency Therapeutics, Inc. (\u201cFrequency\u201d or the \u201cCompany\u201d) (NASDAQ: FREQ) securities from November 16, 2020 through March 22, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Frequency is a Massachusetts-based pharmaceutical company focused on the development of treatments … <\/p>\n

Continue reading “INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-514240","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nINVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 NEW YORK–(BUSINESS WIRE)– The law firm of Kirby McInerney LLP announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Frequency Therapeutics, Inc. (\u201cFrequency\u201d or the \u201cCompany\u201d) (NASDAQ: FREQ) securities from November 16, 2020 through March 22, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Frequency is a Massachusetts-based pharmaceutical company focused on the development of treatments … Continue reading "INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-16T23:03:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021\",\"datePublished\":\"2021-07-16T23:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/\"},\"wordCount\":527,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/\",\"name\":\"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-16T23:03:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 - Market Newsdesk","og_description":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 NEW YORK–(BUSINESS WIRE)– The law firm of Kirby McInerney LLP announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Frequency Therapeutics, Inc. (\u201cFrequency\u201d or the \u201cCompany\u201d) (NASDAQ: FREQ) securities from November 16, 2020 through March 22, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Frequency is a Massachusetts-based pharmaceutical company focused on the development of treatments … Continue reading \"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-16T23:03:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021","datePublished":"2021-07-16T23:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/"},"wordCount":527,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/","name":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-16T23:03:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210716005469r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-against-frequency-therapeutics-inc-and-encourages-investors-to-contact-the-firm-before-august-2-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm Before August 2, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=514240"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514240\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=514240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=514240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=514240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}